Dimensional Fund Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

Dimensional Fund Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,394	Closed	-$43K	–	3518
2021 Q4	$43K	Hold	1,394	–	–	﹤0.01%	3501
2021 Q3	$46K	Buy	1,394 +254	+22%	+$7.51K	﹤0.01%	3477
2021 Q2	$34K	Buy	+1,140	New	+$31.6K	﹤0.01%	3451
2019 Q2	–	Sell	-1,770	Closed	-$51K	–	3468
2019 Q1	$51K	Hold	1,770	–	–	﹤0.01%	3411
2018 Q4	$32K	Buy	1,770 +230	+15%	+$5.48K	﹤0.01%	3417
2018 Q3	$55K	Buy	+1,540	New	+$53.8K	﹤0.01%	3388

Other funds holding CKPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dimensional Fund Advisors's CKPT Position: Q1 2022 in Review

Dimensional Fund Advisors sold out of Checkpoint Therapeutics (CKPT) in Q1 2022, closing a stake of 1,394 shares — an estimated $43K sold.

Dimensional Fund Advisors first reported a position in CKPT in Q3 2018 and held it in 6 quarters. The position peaked at $55K in Q3 2018. 67 funds tracked by Wall St. Rank hold CKPT as of Q1 2022.

Dimensional Fund Advisors reported no remaining Checkpoint Therapeutics position as of Q1 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 1,394 Checkpoint Therapeutics shares in Q1 2022, an estimated $43K.
Dimensional Fund Advisors first reported a position in Checkpoint Therapeutics in Q3 2018 and held it in 6 quarters.
Dimensional Fund Advisors's Checkpoint Therapeutics position peaked at $55K in Q3 2018.
67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2022.

Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.